Skip to main content
Equibles

Donald J. Santel

Board Member

Jade Biosciences, Inc. (JBIO)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Donald J. Santel

Donald J. Santel is recorded as Board Member at Jade Biosciences, Inc. (JBIO). Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that Donald J. Santel resigned as Aerovate's board of directors, effective April 28, 2025. Jade Biosciences, Inc. reported in an 8-K filed January 23, 2023 that Donald J. Santel was appointed member of the Board, effective January 19, 2023.

“On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate's board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
Jade Biosciences, Inc. Form 8-K, filed May 1, 2025 · Read the filing
“Effective as of January 19, 2023 (the "Effective Date"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Aerovate Therapeutics, Inc. (the "Company"), the Board appointed Donald J. Santel as a member of the Board.”
Jade Biosciences, Inc. Form 8-K, filed January 23, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Jade Biosciences, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.